Rafael Dominguez-Blanco
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CXCR3 signaling promotes Delta One T cell recruitment and antitumor efficacy in colorectal cancer.
Journal: Journal for immunotherapy of cancer
Published: April 29, 2026
γδ T Cells for Cancer Immunotherapy: Unconventional Players Take the Spotlight.
Journal: Annual review of immunology
Published: February 27, 2026
Follow the "DOTs": Vδ1+ γδ T cells as effectors of cancer immunotherapy.
Journal: The Journal of experimental medicine
Published: February 11, 2026
Regulatory T cells sabotage anti-tumor γδ T cells by creating IL-2-deficient environments.
Journal: The Journal of experimental medicine
Published: October 14, 2025
How could γδ T cells change the treatment landscape for colorectal cancers?
Journal: Immunotherapy
Published: October 11, 2025
Processing human colon cancer specimens for in vitro cytotoxicity assays.
Journal: Methods in cell biology
Published: November 08, 2024
An orthotopic metastatic xenograft model of colorectal cancer.
Journal: Methods in cell biology
Published: November 08, 2024
Dual modulation of cytotoxic and checkpoint receptors tunes the efficacy of adoptive Delta One T cell therapy against colorectal cancer.
Journal: Nature cancer
Published: May 16, 2024
CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells.
Journal: Blood
Published: October 19, 2023
The emerging roles of γδ T cells in cancer immunotherapy.
Journal: Nature reviews. Clinical oncology
Published: December 08, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026